We are live on ! Find out more
INGN icon

Inogen

220 hedge funds and large institutions have $2.5B invested in Inogen in 2017 Q4 according to their latest regulatory filings, with 38 funds opening new positions, 80 increasing their positions, 80 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

52% more first-time investments, than exits

New positions opened: 38 | Existing positions closed: 25

23% more capital invested

Capital invested by funds: $2.03B → $2.5B (+$468M)

6% more funds holding

Funds holding: 208220 (+12)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

0% more repeat investments, than reductions

Existing positions increased: 80 | Existing positions reduced: 80

9% less call options, than puts

Call options by funds: $5.42M | Put options by funds: $5.93M

2.51% less ownership

Funds ownership: 103.18%100.68% (-2.5%)

Holders
220
Holders Change
+12
Holders Change %
+5.77%
% of All Funds
4.99%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
38
Increased
80
Reduced
80
Closed
25
Calls
$5.42M
Puts
$5.93M
Net Calls
-$513K
Net Calls Change
-$139K
Name Holding Trade Value Shares
Change
Change in
Stake
Comerica Bank
76
Comerica Bank
Texas
$3M +$756K +6,870 +38%
SCM
77
Sterling Capital Management
North Carolina
$2.99M -$697K -6,334 -20%
RA
78
Royce & Associates
New York
$2.88M -$110 -1 -0%
AllianceBernstein
79
AllianceBernstein
Tennessee
$2.88M -$1.13M -10,220 -30%
EI
80
EAM Investors
California
$2.82M -$1.5M -13,580 -36%
CEP
81
Chicago Equity Partners
Illinois
$2.71M +$734K +6,670 +41%
LCG
82
Lisanti Capital Growth
New York
$2.59M +$733K +6,655 +44%
ZIM
83
Zacks Investment Management
Illinois
$2.56M +$56.9K +517 +2%
ACM
84
Atika Capital Management
New York
$2.5M -$3.08M -27,946 -57%
UBS Group
85
UBS Group
Switzerland
$2.41M +$653K +5,930 +41%
GCP
86
GSA Capital Partners
United Kingdom
$2.38M +$582K +5,288 +36%
AQR Capital Management
87
AQR Capital Management
Connecticut
$2.34M +$601K +5,454 +38%
3C
88
361 Capital
Colorado
$2.34M -$41.5K -377 -2%
MWNA
89
Marshall Wace North America
New York
$2.29M -$908K -8,246 -30%
BIM
90
Bogle Investment Management
Massachusetts
$2.27M +$2.1M +19,102 New
Macquarie Group
91
Macquarie Group
Australia
$2.26M -$478K -4,337 -19%
Two Sigma Advisers
92
Two Sigma Advisers
New York
$2.21M -$716K -6,500 -26%
First Trust Advisors
93
First Trust Advisors
Illinois
$2.13M -$831K -7,551 -30%
HI
94
HBK Investments
Texas
$2.13M +$1.2M +10,887 +156%
BAMCO Inc
95
BAMCO Inc
New York
$2.02M -$661K -6,000 -26%
CAM
96
Columbia Asset Management
Michigan
$1.97M -$76K -690 -4%
Bank of Montreal
97
Bank of Montreal
Ontario, Canada
$1.96M -$3.55M -32,197 -66%
GC
98
Guggenheim Capital
Illinois
$1.96M +$1.54M +13,950 +564%
RAM
99
Redmond Asset Management
Virginia
$1.96M
OSAM
100
O'Shaughnessy Asset Management
Connecticut
$1.94M +$243K +2,210 +16%

INGN Hedge Fund Activity: Q4 2017 in Review

220 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Inogen (INGN) for Q4 2017, worth a combined $2.5B — up 23% from $2.03B a quarter earlier.

Buyers outnumbered sellers: 38 funds opened new INGN positions and 25 closed out — a net gain of 13 holders — while 80 added to existing stakes and 80 trimmed.

The largest buyer was Millennium Management, adding an estimated $25.2M. The largest seller was PFM Health Sciences, cutting an estimated $16.4M.

  • 220 institutional investors held Inogen (INGN) as of Q4 2017, up from 208 in Q3 2017.
  • Funds reported $2.5B of Inogen stock for Q4 2017, up 23% quarter-over-quarter.
  • 38 funds opened new Inogen positions in Q4 2017 and 25 closed out, a net change of +13 holders.
  • The largest Inogen buyer in Q4 2017 was Millennium Management, an estimated $25.2M added.
  • The largest Inogen seller in Q4 2017 was PFM Health Sciences, an estimated $16.4M sold.

Based on aggregated 13F filings for Q4 2017.